First Trust Bloomberg R&D Leaders ETF (RND) seeks to track the Bloomberg R&D Leaders Index, which measures the performance of companies that demonstrate leadership in research and development spending relative to their market capitalization and revenue, focusing on innovation-driven businesses across global markets.
How It Works
RND uses a rules-based, passive approach that selects companies based on quantitative R&D metrics including R&D expenditure as a percentage of revenue and market cap. The index methodology screens for firms with substantial innovation investments, then weights holdings based on modified market capitalization. Portfolio rebalancing occurs semi-annually to maintain alignment with index changes and capture evolving R&D leadership across sectors including technology, healthcare, and industrials.
Key Features
- Targets innovation leaders through quantitative R&D spending metrics rather than subjective growth assessments or traditional fundamental factors
- Provides global exposure to R&D-intensive companies across multiple sectors, not limited to traditional technology classifications
- Recently launched in May 2024, offering early access to this specialized factor-based investment strategy
Risks
- This ETF can lose value if R&D-heavy companies underperform due to failed innovation projects or extended development timelines without immediate revenue
- Concentration in growth-oriented, R&D-intensive sectors creates vulnerability to rising interest rates which disproportionately impact future cash flow valuations
- As a new ETF with limited assets, liquidity constraints and tracking errors may occur during volatile market periods
Who Should Own This
Best suited as a satellite holding (5-15% of equity allocation) for growth-oriented investors with 3-7 year time horizons seeking exposure to innovation themes. Requires medium-to-high risk tolerance due to growth stock volatility and new fund uncertainty. Appeals to thematic investors wanting R&D exposure beyond traditional technology sector ETFs.